Announcements

September 13, 2016

Antibody discovery could help create improved flu vaccines

Our newly published paper in Nature Communications discusses a new broadly neutralizing antibody in the immune system that blocks infection by a wide range of influenza viruses. These findings suggest potential strategies for developing "universal" flu vaccines, providing long lasting protection. Read the press release here, and access the paper in Nature Communications.  

August 4, 2016

Access to primary tissue for humanized mouse studies 
The Marasco Lab has recently been approved to collect matched PBMCs and tumor tissues from renal cell carcinoma patients that are undergoing therapeutic nephrectomy! This is the second cancer, in addition to ovarian cancer, that we will have access to primary tissue for our in vitro and in vivo humanized mouse studies that will examine monoclonal antibodies and CAR T cells.

Feb 3, 2012

Humanized Mouse Program open to research community
Cutting edge research requires cutting edge technology.  Humanized mouse models offers a platform to bring research projects to the next level.  Since 2007, the Marasco Laboratory has successfully developed, characterized and optimized humanized mouse models.  We currently have three models: hNSG, BLT and GTL plus more in development.  In June 2011 we opened our expertise to the Harvard University Center for AIDS Research (HU-CFAR) community.  Now we are expanding our Humanized Mouse Program to the research community at large.  Investigators can use our models in the form of collaborative or sponsored research programs.  We will guide you through the process to make it an easy and successful experience.  For additional details, please visit our website at www.humouse.org.

 


June 6, 2011

Launch of Humanized Mouse Program
The Marasco Lab launched its Humanized Mouse Program in June 2011.  The Lab offers humanized mouse models to the Center of AIDS Research (CFAR) research community in order to enable advanced translational and preclinical studies.  The services are part of the Harvard University Center for AIDS Research.